Trevi Therapeutics Aktie
6,53
USD
+0,06
USD
+0,85
%
6,53
USD
+0,07
USD
+1,08
%
Werbung
Trevi Therapeutics Aktie Analyse
03.06.19 | Trevi Therapeutics Outperform | BMO Capital Markets | |
03.06.19 | Trevi Therapeutics Buy | Needham & Company, LLC |
Werbung
Werbung